A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes
- PMID: 9930320
- DOI: 10.1038/sj.gt.3300696
A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes
Abstract
Genetic engineering of T lymphocytes for adoptive clinical immunotherapy calls for efficient gene transduction methods. Therefore, a transient retroviral gene transduction system 'STITCH' was developed comprising pSTITCH retroviral vector encoding the transgene, plasmids encoding Moloney murine leukemia virus gag/pol and gibbon ape leukemia virus envelope, and the human kidney cell line 293T as a packaging line. Cotransfection of retroviral vector and packaging plasmids in 293T cells results in the production of GALV env pseudotyped viral particles with a titer of 10(7) infectious units per milliliter. The 'STITCH' gene transduction system efficiently transduces genes into activated human T lymphocytes derived from healthy donors and cancer patients. The efficacy of gene transduction is donor-independent. A direct application of the 'STITCH' gene transduction system is the genetic engineering of activated human T lymphocytes to induce expression of antibody based chimeric receptors in their membrane. Introduction of these chimeric receptors into activated human T lymphocytes graft these cells with specificity for, for example, renal cell carcinoma. In order to study the effect of the chimeric receptor gene structure on the processes ultimately leading to functional membrane expression, we designed a number of different chimeric receptor gene structures and subsequently compared their membrane expression on 293T cells and activated human T lymphocytes. Distinct membrane expression densities were observed on 293T cells and human T lymphocytes for the different chimeric receptor gene constructs. Gene transduction of activated human T lymphocytes with four out of five chimeric receptor gene constructs resulted in functional expression of chimeric receptor as demonstrated by specific recognition and cytolysis of renal cell carcinoma.
Similar articles
-
Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.Cytotherapy. 2006;8(6):542-53. doi: 10.1080/14653240601056396. Cytotherapy. 2006. PMID: 17148030
-
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.Cancer Gene Ther. 2002 Jul;9(7):613-23. doi: 10.1038/sj.cgt.7700477. Cancer Gene Ther. 2002. PMID: 12082462
-
Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.Gene Ther. 2007 Apr;14(7):595-603. doi: 10.1038/sj.gt.3302906. Epub 2007 Jan 18. Gene Ther. 2007. PMID: 17235289
-
The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.Cancer Detect Prev. 1994;18(1):43-50. Cancer Detect Prev. 1994. PMID: 8162605 Review.
-
Genetically marking human cells--results of the first clinical gene transfer studies.Cancer Gene Ther. 1995 Jun;2(2):125-36. Cancer Gene Ther. 1995. PMID: 7621260 Review.
Cited by
-
Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation.Mucosal Immunol. 2021 May;14(3):652-666. doi: 10.1038/s41385-020-00354-7. Epub 2020 Nov 12. Mucosal Immunol. 2021. PMID: 33184477
-
CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.Front Immunol. 2023 Nov 10;14:1290488. doi: 10.3389/fimmu.2023.1290488. eCollection 2023. Front Immunol. 2023. PMID: 38022580 Free PMC article.
-
Most Do, but Some Do Not: CD4⁺CD25- T Cells, but Not CD4⁺CD25⁺ Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR).Cancers (Basel). 2017 Aug 29;9(9):112. doi: 10.3390/cancers9090112. Cancers (Basel). 2017. PMID: 28850063 Free PMC article.
-
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.Clin Dev Immunol. 2012;2012:586314. doi: 10.1155/2012/586314. Epub 2012 Feb 12. Clin Dev Immunol. 2012. PMID: 22400038 Free PMC article.
-
OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells.Oncoimmunology. 2012 Jul 1;1(4):458-466. doi: 10.4161/onci.19855. Oncoimmunology. 2012. PMID: 22754764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous